concord-drugs-ltd
Concord Drugs Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 11.85 | 6.35 | 14.47 |
| Operating Expense | 11.05 | 5.62 | 14.28 |
| Net Profit | 0.05 | 0.01 | -0.35 |
| Net Profit Margin | 0.42 | 0.16 | -2.42 |
| Earning Per Share | 0.05 | 0.01 | -0.35 |
| EBIDTA | 0.81 | 0.74 | 0.20 |
| Effective Tax Rate | 3.75 | 2.74 | -115.79 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 11.85 |
| Operating Expense | 11.05 |
| Net Profit | 0.05 |
| Net Profit Margin | 0.42 |
| Earning Per Share | 0.05 |
| EBIDTA | 0.81 |
| Effective Tax Rate | 3.75 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 43.26 | 51.31 | 58.96 |
| Operating Expenses Annual | 39.58 | 46.97 | 53.36 |
| Operating Profit Annual | 3.69 | 4.35 | 5.69 |
| Interest Annual | 1.59 | 1.62 | 1.68 |
| Depreciation | 1.54 | 1.60 | 1.76 |
| Net Profit Annual | 0.42 | 0.89 | 1.59 |
| Tax Annual | 0.14 | 0.23 | 0.65 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 43.26 |
| Operating Expenses Annual | 39.58 |
| Operating Profit Annual | 3.69 |
| Interest Annual | 1.59 |
| Depreciation | 1.54 |
| Net Profit Annual | 0.42 |
| Tax Annual | 0.14 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.08 | 0.04 | 0.04 |
| Cash Flow from Operations | 1.96 | 2.24 | 0.77 |
| Cash Flow from Investing | -1.21 | -2.27 | -2.44 |
| Cash Flow from Financing | -0.69 | 0.05 | 1.68 |
| Cash Flow at the End | 0.14 | 0.08 | 0.04 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.08 |
| Cash Flow from Operations | 1.96 |
| Cash Flow from Investing | -1.21 |
| Cash Flow from Financing | -0.69 |
| Cash Flow at the End | 0.14 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 8.53 | 8.48 | 9.65 |
| PBIT Margin (%) | 4.97 | 5.36 | 6.67 |
| PBT Margin (%) | 1.85 | 2.07 | 2.72 |
| Net PROFIT Margin (%) | 0.97 | 1.73 | 2.70 |
| Return On Networth / Equity (%) | 1.28 | 2.96 | 5.77 |
| Return On Networth /Employed (%) | 4.25 | 5.67 | 8.80 |
| Return On Assets (%) | 0.83 | 1.84 | 3.56 |
| Total Debt / Equity (X) | 0.47 | 0.53 | 0.53 |
| Asset Turnover Ratio (%) | 0.86 | 1.06 | 1.32 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 8.53 |
| PBIT Margin (%) | 4.97 |
| PBT Margin (%) | 1.85 |
| Net PROFIT Margin (%) | 0.97 |
| Return On Networth / Equity (%) | 1.28 |
| Return On Networth /Employed (%) | 4.25 |
| Return On Assets (%) | 0.83 |
| Total Debt / Equity (X) | 0.47 |
| Asset Turnover Ratio (%) | 0.86 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 10.99 | 12.22 | 13.33 |
| Total Current Assets Annual | 41.38 | 41.40 | 41.89 |
| Non Current Assets Annual | 14.92 | 15.23 | 14.55 |
| Total Shareholders Funds Annual | 33.82 | 31.70 | 28.36 |
| Total Assets Annual | 56.30 | 56.63 | 56.45 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 10.99 |
| Total Current Assets Annual | 41.38 |
| Non Current Assets Annual | 14.92 |
| Total Shareholders Funds Annual | 33.82 |
| Total Assets Annual | 56.30 |
EPS (INR)
Expected
0.04
Reported
0.04
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
